For those living with ALS, every day matters. They cannot afford disruptions in research, treatment access, and support. This reauthorization ensures that the momentum we have built over the past five years will continue, keeping pathways to promising investigational treatments open while supporting the research needed to find better treatments and, ultimately, a cure. I’m grateful to Senator Coons, Representatives Quigley and Calvert, and especially the ALS community, whose persistence helped us get this legislation across the finish line before the authorization expired.